As E4, but not E2, shows differing effects on clinical AD in EA/AA69, we infer that our observations regarding APOE haplotype effects on astrocytic genes in the LC are likely an E2-mediated, AD-protective phenomenon. The gene discussed is APOE; the disease is Alzheimer disease.